SEQUENT SCIENTIFIC
|
The Current P/S Ratio of SEQUENT SCIENTIFIC is 3.09.
Share Price | ₹179.1 | Jan 14,2025 |
Market Cap | ₹4,481.6 Cr | |
Sales-TTM | ₹1,449.4 Cr | TTM-Consolidated Results |
Price/Sales | 3.09x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of SEQUENT SCIENTIFIC
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹4,481.6 Cr] as on Jan 14,2025
(/) Sales [ ₹1,449.4 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 3.09x ]
Thus, for SEQUENT SCIENTIFIC , the investors are currently willing to pay '3.09 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of SEQUENT SCIENTIFIC !
The chart below summarizes the trend in P/S Ratio of SEQUENT SCIENTIFIC over the last five years.
Historical PS (Price/Sales) ratio chart of SEQUENT SCIENTIFIC
PS Ratio Performance Analysis for SEQUENT SCIENTIFIC
- SEQUENT SCIENTIFIC 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 2.35x.
- SEQUENT SCIENTIFIC 's operated at median p/e ratio of 2.1x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SEQUENT SCIENTIFIC 's p/e ratio peaked in Mar2021 at 4.39x.
- SEQUENT SCIENTIFIC 's p/e ratio hit its five-year low in Mar2023 of 1.27x.
How does SEQUENT SCIENTIFIC 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
SEQUENT SCIENTIFIC | 1,449.4 | 3.09 | 4,481.6 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 50,307.7 | 8.44 | 424,382.0 |
CIPLA LTD | 26,512.0 | 4.41 | 116,943.0 |
DR REDDYS LABORATORIES LTD | 30,084.9 | 3.71 | 111,588.0 |
ZYDUS LIFESCIENCES LTD | 21,483.5 | 4.69 | 100,704.0 |
DIVIS LABORATORIES LTD | 8,614.0 | 18.48 | 159,224.0 |
MANKIND PHARMA LTD | 11,018.0 | 10.00 | 110,215.0 |
TORRENT PHARMACEUTICALS LTD | 11,225.0 | 9.81 | 110,142.0 |
LUPIN LTD | 21,431.3 | 4.59 | 98,330.0 |
AUROBINDO PHARMA LTD | 30,295.0 | 2.25 | 68,238.4 |
ABBOTT INDIA LTD | 6,066.1 | 9.90 | 60,041.1 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs SEQUENT SCIENTIFIC 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.25x |
Max industry PS | 18.48x |
Median industry PS | 4.69x |
Average industry PS | 7.22x |
You may also like the below Video Courses